Revisiting the potential role of BCG and MMR vaccines in COVID-19

Despite the development and deployment of effective COVID-19 vaccines, many regions remain poorly covered. Seeking alternative tools for achieving immunity against COVID-19 remains to be of high importance. “Trained immunity” is the nonspecific immune response usually established through administeri...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayram, Zeina, Musharrafieh, Umayya, Bizri, Abdul Rahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450304/
https://www.ncbi.nlm.nih.gov/pubmed/35848578
http://dx.doi.org/10.1177/00368504221105172
Descripción
Sumario:Despite the development and deployment of effective COVID-19 vaccines, many regions remain poorly covered. Seeking alternative tools for achieving immunity against COVID-19 remains to be of high importance. “Trained immunity” is the nonspecific immune response usually established through administering live attenuated vaccines and is a potential preventive tool against unrelated infections. Evidence regarding a possible protective role for certain live attenuated vaccines against COVID-19 has emerged mainly for those administered as part of childhood vaccination protocols. This review summarizes the relevant literature about the potential impact of Bacille Calmette–Guérin (BCG) and measles, mumps and rubella (MMR) vaccines on COVID-19. Existing available data suggest a potential role for BCG and MMR in reducing COVID-19 casualties and burden. However, more investigation and comparative studies are required for a better understanding of their impact on COVID-19 outcomes.

Ejemplares similares